newest glp 1 New GLP-1 Guidelines for Type 2 Diabetes in 2025 GLP-1 Agonists: A Comprehensive Overview

The researchers concluded that there was small improvement, but due to the limited number of patients in the study, firm conclusions could not be drawn

The full results from Lillys ATTAIN-1 trial were published in the NEJM this week, evaluating orforglipron for obesity treatment

Growth of online prescribing platforms and private weight-management clinics is improving access to GLP-1 therapies outside traditional hospital settings

Inhibition of plaque progression and promotion of plaque stability by glucagon-like peptide-1 receptor agonist: Serial in vivo findings from iMap-IVUS in Watanabe heritable hyperlipidemic rabbits

Patrick R

Their lipid structure penetrates cellular barriers effectively, which helps deliver NAD+ throughout the body's tissues